unknown
Stage
1
Investors
About
Inherent Biosciences develops molecular diagnostic tests that combine epigenetic biomarkers with AI-driven analysis to assess and improve reproductive health and fertility outcomes.
Explore Inherent Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.